BriaCell Therapeutics Corporation
4 clinical trials · Sponsor
◉ Watch BriaCell Therapeutics Corporation
| Record | Firm | Date |
|---|---|---|
| A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer (NCT06471673) | BriaCell Therapeutics Corporation | 2024-05-29 |
| Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. (NCT06072612) | BriaCell Therapeutics Corporation | 2023-12-05 |
| Combination Study of SV-BR-1-GM With Retifanlimab (NCT03328026) | BriaCell Therapeutics Corporation | 2018-03-16 |
Track BriaCell Therapeutics Corporation automatically
Every clearance here is in the API, with alerts when new ones post.